Summary Of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2019

Summary Of Significant Accounting Policies [Abstract]

Summary Of Net Revenue Disaggregated By Product And Region

	Three Months Ended March 31,				Nine Months Ended March 31,
	2019		2018		2019		2018
U.S., Canada and Latin America
Devices	$	181.3	$	168.1	$	540.2	$	499.7
Masks and other		168.7		149.4		494.8		443.7
Total Sleep and Respiratory Care	$	350.0	$	317.5	$	1,035.0	$	943.4
Software as a Service		79.9		39.9		190.6		116.6
Total	$	429.9	$	357.4	$	1,225.6	$	1,060.0
Combined Europe, Asia and other markets
Devices	$	155.2	$	160.1	$	463.0	$	451.8
Masks and other		77.1		74.1		213.0		204.8
Total Sleep and Respiratory Care	$	232.3	$	234.2	$	676.0	$	656.6
Global revenue
Devices	$	336.5	$	328.2	$	1,003.2	$	951.5
Masks and other		245.8		223.5		707.8		648.5
Total Sleep and Respiratory Care	$	582.3	$	551.7	$	1,711.0	$	1,600.0
Software as a Service		79.9		39.9		190.6		116.6
Total	$	662.2	$	591.6	$	1,901.6	$	1,716.6

Summary Of Contract Balances

	March 31, 2019		June 30, 2018		Balance sheet caption
Contract assets
Accounts receivable, net	$	511,403	$	483,681	Accounts receivable, net
Unbilled revenue, current		10,443		13,342	Prepaid expenses and other current assets
Unbilled revenue, non-current		3,825		2,973	Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current		(82,288)		(60,828)	Deferred revenue (current liabilities)
Deferred revenue, non-current		(76,703)		(71,596)	Deferred revenue (non-current liabilities)